|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenues | |||
| Gross premiums written | |||
| Reinsurance premiums ceded | |||
| Net premiums written | |||
| Change in net unearned premiums | |||
| Net premiums earned | |||
| Net investment income | |||
| Net realized and unrealized investment gains/(losses) | |||
| Other income | |||
| Total revenues before net gain on distribution of The Fidelis Partnership | |||
| Net gain on distribution of The Fidelis Partnership | |||
| Total revenues | |||
| Expenses | |||
| Losses and loss adjustment expenses | |||
| Policy acquisition expenses (includes The Fidelis Partnership commissions of $328.8 (2024: $311.1 and 2023: $225.3)) | |||
| General and administrative expenses | |||
| Corporate and other expenses | |||
| Net foreign exchange (gains)/losses | |||
| Financing costs | |||
| Total expenses | |||
| Income before income taxes | |||
| Income tax (expense)/benefit | |||
| Net income attributable to non-controlling interests | |||
| Net income | |||
| Other comprehensive income | |||
| Unrealized gains on available-for-sale investments | |||
| Reclassification of net realized losses/(gains) recognized in net income | |||
| Income tax expense, all of which relates to unrealized gains on available-for-sale investments | |||
| Currency translation adjustments | |||
| Total other comprehensive income | |||
| Comprehensive income attributable to common shareholders | |||
| Per share data | |||
| Earnings per common share (in dollars per share) | |||
| Earnings per diluted common share (in dollars per share) | |||
| Weighted average basic common shares outstanding (in shares) | |||
| Weighted average diluted common shares outstanding (in shares) |
Loading...
